TrialSurgery today2011

Clinical impact of combined transplantation of autologous skeletal myoblasts and bone marrow mononuclear cells in patients with severely deteriorated ischemic cardiomyopathy.

Tomoyuki Fujita et al.PubMed ↗Publisher ↗

No numbers read from the abstract.